Orient Pharma Co., Ltd.

NT$22.00As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4166Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (0.87%)
Div yield —
ROE 10.42%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.07
PE TTM 22.48
TSR TTM (14.23%)
Mkt cap NT$5.347B
ROIC 10.46%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$23
6.65%
(30.72%)
Hold 4|2|2|3|10
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.28
0.32
0.30
0.29
10.98%
21.06%
9.89%
(1.16%)
RevenueNT$M
368.2
387.2
398.2
412.1
5.11%
11.00%
11.96%
9.91%
Peers (US$161.5M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.199
0.087
0.066
EBIT/Intx
3.008
0.263
0.250
Own earn%
(61.66)
(13.91)
(3.95)
Sh yield%
39.49
22.20
22.28
Owners
Insiders/Inst%
0.57
35.69
Short interest%
0.93
SBC / revenue%
3.92
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
15–19
$1 testx
−0.3
Incr. ROIC%
18